You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Pseudoephedrine sulfate - Generic Drug Details


✉ Email this page to a colleague

« Back to Dashboard


What are the generic drug sources for pseudoephedrine sulfate and what is the scope of freedom to operate?

Pseudoephedrine sulfate is the generic ingredient in one branded drug marketed by Schering Plough and is included in one NDA. Additional information is available in the individual branded drug profile pages.

There are eight drug master file entries for pseudoephedrine sulfate.

Summary for pseudoephedrine sulfate
Recent Clinical Trials for pseudoephedrine sulfate

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
BayerPhase 1
BayerPhase 4
Magna Pharmaceuticals, Inc.Phase 3

See all pseudoephedrine sulfate clinical trials

US Patents and Regulatory Information for pseudoephedrine sulfate

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Schering Plough AFRINOL pseudoephedrine sulfate TABLET, EXTENDED RELEASE;ORAL 018191-001 Approved Prior to Jan 1, 1982 DISCN Yes No ⤷  Subscribe ⤷  Subscribe ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Pseudoephedrine sulfate Market Analysis and Financial Projection Experimental

Market Dynamics and Financial Trajectory of Pseudoephedrine Sulfate

Introduction to Pseudoephedrine Sulfate

Pseudoephedrine sulfate is a widely used decongestant found in various over-the-counter (OTC) and prescription medications. It is known for its efficacy in relieving nasal congestion associated with colds, allergies, and sinus infections.

Market Size and Forecast

The global pseudoephedrine market, which includes pseudoephedrine sulfate, has been experiencing significant fluctuations. As of 2023, the market size was valued at a substantial amount, and it is forecasted to grow, albeit at a readjusted rate, by 2030[1].

Regional Market Analysis

The pseudoephedrine market is diverse and spread across various regions. The demand for pseudoephedrine sulfate varies by region, influenced by factors such as regulatory environments, consumer preferences, and the prevalence of respiratory conditions. Key regions include North America, Europe, Asia-Pacific, and Latin America, each with its own market dynamics and growth prospects[1].

Types and Applications

Pseudoephedrine sulfate is available in several formulations, including tablets, capsules, and liquid solutions. It is often sold as a stand-alone product or co-formulated with other active ingredients like analgesics and antitussives. The primary applications include treating nasal congestion, sinusitis, and other respiratory issues[4].

Regulatory Environment

The regulatory landscape for pseudoephedrine sulfate is stringent due to its potential for misuse in the production of methamphetamine. The Combat Methamphetamine Epidemic Act (CMEA) has imposed strict limits on the sale and purchase of pseudoephedrine-containing products, including pseudoephedrine sulfate. For example, the CMEA sets limits on the number of tablets that can be purchased, such as 146 tablets for 30 mg pseudoephedrine HCl, which is similar to the restrictions on pseudoephedrine sulfate[2].

Financial Trajectory

Sales and Revenue

Between 2012 and 2021, pseudoephedrine products, including those containing pseudoephedrine sulfate, saw significant sales. During this period, approximately 13.2 billion units of pseudoephedrine products were purchased, amounting to $3.8 billion in pharmacy expenditures. However, the sales of pseudoephedrine-containing products have been declining, from 1.68 billion units in 2012 to 0.98 billion units in 2021[4].

Market Trends

Despite the decline in sales, pseudoephedrine sulfate remains a crucial component in the decongestant market. The market is influenced by consumer preferences and the availability of alternative decongestants. For instance, the ineffectiveness of oral phenylephrine, another common decongestant, has led to increased scrutiny and potential regulatory changes, which could impact the pseudoephedrine market positively[4].

Competitive Landscape

The pseudoephedrine market is highly competitive, with numerous products available, including stand-alone formulations and combination products. As of 2021, there were 495 pseudoephedrine products on the market, with 54 being stand-alone products and 441 being combination products. This competition drives innovation and pricing strategies within the market[4].

SWOT Analysis

Strengths

  • Efficacy: Pseudoephedrine sulfate is clinically proven to be effective in relieving nasal congestion.
  • Wide Availability: It is available in various formulations and is widely distributed across different retail and non-retail outlets.
  • Brand Recognition: Many well-known brands incorporate pseudoephedrine sulfate into their products.

Weaknesses

  • Regulatory Restrictions: Strict regulations due to its potential misuse in methamphetamine production limit its sale and purchase.
  • Declining Sales: The sales of pseudoephedrine-containing products have been declining over recent years.
  • Competition from Alternatives: The availability of other decongestants, such as intranasal decongestants, poses a competitive threat.

Opportunities

  • Growing Demand for Respiratory Treatments: Increasing prevalence of respiratory conditions such as allergies and sinus infections.
  • Potential Regulatory Changes: If oral phenylephrine is removed from the market, pseudoephedrine sulfate could see increased demand as an alternative.
  • Innovative Formulations: Opportunities to develop new formulations that combine pseudoephedrine sulfate with other active ingredients.

Threats

  • Regulatory Changes: Potential changes in regulations could further restrict the sale and purchase of pseudoephedrine sulfate.
  • Public Perception: Negative publicity about the ineffectiveness of oral decongestants could impact consumer confidence.
  • Economic Factors: Economic downturns can affect consumer spending on OTC medications.

PESTLE Analysis

Political

  • Regulatory Environment: Strict regulations and potential changes in the regulatory process can significantly impact the market.
  • Legislation: Laws like the CMEA and potential reforms in the nonprescription drug review process affect the market dynamics.

Economic

  • Consumer Spending: Economic conditions influence consumer spending on OTC medications.
  • Pharmacy Expenditures: The financial trajectory is heavily influenced by pharmacy expenditures, which can fluctuate based on economic factors.

Social

  • Consumer Preferences: Changes in consumer preferences towards health and wellness products can impact demand.
  • Public Health: The prevalence of respiratory conditions and public health campaigns can influence market demand.

Technological

  • Innovative Formulations: Advances in pharmaceutical technology can lead to new and more effective formulations.
  • Data Infrastructure: Improvements in data infrastructure can enhance post-market evaluations and regulatory decisions.

Environmental

  • Supply Chain: Environmental factors can impact the supply chain, particularly in the sourcing of raw materials.
  • Sustainability: Consumer demand for sustainable products can influence the packaging and production processes.

Legal

  • FDA Regulations: FDA advisory committee recommendations and potential actions can significantly impact the market.
  • Litigation: Legal challenges related to the efficacy and safety of pseudoephedrine sulfate can affect market dynamics.

Key Players and Market Share

The pseudoephedrine market includes several key players, each with a significant market share. These companies invest heavily in research and development to maintain their competitive edge. The market share is distributed among various manufacturers, with some companies specializing in stand-alone pseudoephedrine sulfate products while others focus on combination products[5].

Consumer Behavior and Preferences

Consumer behavior plays a crucial role in the pseudoephedrine market. Consumers are increasingly seeking effective and safe decongestants, which has led to a decline in the sales of less effective alternatives like oral phenylephrine. The preference for stand-alone pseudoephedrine products over combination products is also a significant factor influencing market dynamics[4].

Future Outlook

The future of pseudoephedrine sulfate is tied to several factors, including regulatory changes, consumer preferences, and the development of new formulations. If oral phenylephrine is removed from the market, pseudoephedrine sulfate could experience a resurgence in demand. Additionally, advancements in pharmaceutical technology and changes in consumer behavior will continue to shape the market.

"Despite a lack of clinical efficacy evidence, phenylephrine was the most common oral decongestant in the U.S. from 2012-2021, with hundreds of millions of units purchased by retail pharmacies annually, and sales remained stable during this time," - University of Pittsburgh–led authors[4].

Key Takeaways

  • Market Size and Forecast: The global pseudoephedrine market, including pseudoephedrine sulfate, is forecasted to grow at a readjusted rate by 2030.
  • Regulatory Environment: Strict regulations due to the potential misuse in methamphetamine production significantly impact the market.
  • Financial Trajectory: Pseudoephedrine products have seen declining sales, but they remain a crucial component in the decongestant market.
  • Competitive Landscape: The market is highly competitive with numerous stand-alone and combination products available.
  • Future Outlook: The market is influenced by regulatory changes, consumer preferences, and the development of new formulations.

FAQs

What is pseudoephedrine sulfate used for?

Pseudoephedrine sulfate is used as a decongestant to relieve nasal congestion associated with colds, allergies, and sinus infections.

Why are there regulatory restrictions on pseudoephedrine sulfate?

Regulatory restrictions are in place due to the potential misuse of pseudoephedrine sulfate in the production of methamphetamine.

How has the sales trend been for pseudoephedrine products?

The sales of pseudoephedrine-containing products have been declining, from 1.68 billion units in 2012 to 0.98 billion units in 2021.

What are the main competitors to pseudoephedrine sulfate in the decongestant market?

The main competitors include other decongestants like oral phenylephrine and intranasal decongestants such as oxymetazoline.

How might regulatory changes impact the pseudoephedrine sulfate market?

If oral phenylephrine is removed from the market, pseudoephedrine sulfate could see increased demand as an alternative. Additionally, changes in the regulatory process for nonprescription drugs could affect the market dynamics.

Sources

  1. Global Pseudoephedrine Hydrochloride Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030. Market Research Reports.
  2. CMEA General Information - Diversion Control Division. U.S. Department of Justice.
  3. Global Pseudoephedrine Market Report 2019: Ken Research. Ken Research.
  4. Billions Spent on “Decongestant” Now Considered Ineffective. U.S. Pharmacist.
  5. Pseudoephedrine Market Industry Report 2024: Size, Share, and Key Growth Opportunities. News Channel Nebraska.

More… ↓

⤷  Subscribe

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.